Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ – biolegacy

Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ

Post author:Sam
Post published:January 21, 2018
Post category:BioPharma

The deal has Sanofi paying $105 per share in cash.
Source: BioSpace